Especially in today’s economic and work environment, we find it helpful – and we therefore thought our clients would also find it helpful – to keep track of the important litigation and regulatory enforcement developments...more
5/27/2020
/ Asset Management ,
CARES Act ,
Clawbacks ,
Commercial Bankruptcy ,
Coronavirus/COVID-19 ,
Disclosure Requirements ,
Enforcement Actions ,
Exchange-Traded Products ,
Financial Industry Regulatory Authority (FINRA) ,
Fraud ,
Fraudulent Conveyance ,
Investment Management ,
Oil & Gas ,
Paycheck Protection Program (PPP) ,
Regulatory Oversight ,
Section 36(b) ,
Securities and Exchange Commission (SEC) ,
Securities Fraud ,
Securities Litigation ,
Shareholder Litigation
Publicly Traded Life Sciences Companies in the United States Are an Increasingly Popular Target of Securities Fraud Class Action Lawsuits -
The past year was particularly noteworthy with respect to the relative number...more
3/19/2015
/ Biotechnology ,
Class Action ,
Compliance ,
Disclosure Requirements ,
Insider Trading ,
Life Sciences ,
Medical Devices ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Publicly-Traded Companies ,
Rule 10b-5 ,
Securities Fraud ,
Surveys